Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric Diabetic Ketoacidosis (DKA) Treatment in the Paediatric ICU (PICU) : A Retrospective Cohort Study
Main finding · Hypoglycaemia (glucose < 70 mg/dL)Result — go to the resultAdjusted odds ratio 0.059 95% CI 0.011–0.323Authors' conclusion
Amongst paediatric patients with DKA treated in the PICU, CGM insertion was independently associated with reduced hypoglycaemia and a lower POC testing burden.
Study context
- Population
- Paediatric patients (< 20 years) admitted to the PICU with DKA between December 2013 and December 2025 receiving continuous IV insulin infusion
- Participants
- 73 patients
- Exposure
- Continuous glucose monitoring (CGM) insertion vs no CGM during PICU stay
- CGMn = 31
- Outcome
- Hypoglycaemia
Methodological detailssingle-centre
- Single-centre
Main finding
Hypoglycaemia (glucose < 70 mg/dL)
Adjusted odds ratio
0.059
95% CI 0.011–0.323
P = 0.001
By group
CGMvs Control
aOR 0.059 (95% CI 0.011–0.323); P = 0.001
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
Hypoglycaemia (glucose < 60 mg/dL)
P = 0.008
Frequency of point-of-care (POC) glucose measurements
- Significantly lower frequency of POC glucose measurements in CGM vs control
Original publication
Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study. Diabetes Obes Metab. Published 8 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →